Ironwood Pharmaceuticals | IRWD - DŁUG





DŁUG Zmiana Data
Acadia Pharmaceuticals USD 54.81M 1.48M 2025-09
Agios Pharmaceuticals USD 44.52M 4.24M 2025-09
Akebia Therapeutics USD 46.51M 7.82M 2025-03
Almirall EUR 342.86M 61.94M 2025-12
Alnylam Pharmaceuticals USD 1.31B 11.39M 2025-09
Amarin USD 0 0 2025-03
Ardelyx USD 207.61M 968K 2025-09
AstraZeneca USD 32.63B 207M 2025-09
Charles River Laboratories USD 2.63B 157.4M 2025-09
Coherus Biosciences USD 294.92M 1.25M 2025-03
Emergent BioSolutions USD 903.2M 495.2M 2023-06
Esperion Therapeutics USD 262.92M 1.76M 2024-09
Halozyme Therapeutics USD 1.51B 1.66M 2025-09
Incyte USD 40.41M 855K 2025-12
Ironwood Pharmaceuticals USD 583.99M 14.83M 2024-12
Karyopharm Therapeutics USD 299.23M 35.14M 2025-12
Lexicon Pharmaceuticals USD 99.51M 243K 2023-12
MacroGenics USD 37.01M 238K 2025-09
Moderna USD 734M 7M 2025-09
Myriad Genetics USD 59.3M 19.7M 2025-03
Pacira USD 372.19M 4.53M 2025-12
PTC Therapeutics USD 2.71B 2.42B 2025-12
Puma Biotechnology USD 89.06M 55.07M 2024-06
Sarepta Therapeutics USD 1.25B 103.69M 2025-09
Takeda JPY 4.85T 208B 2025-12
Ultragenyx Pharmaceutical USD 33.83M 2.46M 2025-09
Vanda Pharmaceuticals USD 4.96M 4.96M 2024-12